Literature DB >> 9890093

Epidemiology.

B A Gäre1.   

Abstract

Epidemiological research in the field of paediatric rheumatology is important for reasons such as the identification of possible aetiological factors, description of the natural history, identification of biologically homogeneous disease groups and health care planning. This review will focus on the epidemiology of 'idiopathic' juvenile arthritis (JA) where data are available for comparison in terms of time, space and ethnic origin. Methodological issues that make comparisons of data difficult, such as case definition, source population and case ascertainment, will be discussed in relation to the data presented. The incidence and prevalence of JA cover a wide range, but, in studies that use similar methodology, an incidence of 5-18 and a prevalence of 30-150 per 100,000 children under the age of 16 is found in Europe and on the American continent. Studies from other parts of the world indicate differences in age of onset and subgroup distribution related to geographical location and/or race.

Entities:  

Mesh:

Year:  1998        PMID: 9890093     DOI: 10.1016/s0950-3579(98)80014-9

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN: 0950-3579


  7 in total

1.  Bilateral Cricoarytenoid Arthritis: A Cause of Recurrent Upper Airway Obstruction in Rheumatoid Arthritis.

Authors:  Pradeep Pradhan; Abhishek Bhardwaj; V P Venkatachalam
Journal:  Malays J Med Sci       Date:  2016-05

Review 2.  Biologic therapies for juvenile arthritis.

Authors:  N Wilkinson; G Jackson; J Gardner-Medwin
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

3.  High-throughput characterization of the functional impact of IgG Fc glycan aberrancy in juvenile idiopathic arthritis.

Authors:  Hao D Cheng; Henning Stöckmann; Barbara Adamczyk; Ciara A McManus; Altan Ercan; Ingrid A Holm; Pauline M Rudd; Margaret E Ackerman; Peter A Nigrovic
Journal:  Glycobiology       Date:  2017-12-01       Impact factor: 4.313

4.  Decreased levels of sCD21 and sCD23 in blood of patients with systemic-juvenile arthritis, polyarticular-juvenile arthritis, and pauciarticular-juvenile arthritis.

Authors:  Anjana Singh; Sebastiaan J Vastert; Berent J Prakken; Harald Illges
Journal:  Rheumatol Int       Date:  2011-02-17       Impact factor: 3.580

5.  Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis: part 1-results of the Canadian model in the Nordic cohort.

Authors:  Veronika Rypdal; Jaime Guzman; Andrew Henrey; Thomas Loughin; Mia Glerup; Ellen Dalen Arnstad; Kristiina Aalto; Marite Rygg; Susan Nielsen; Troels Herlin; Anders Fasth; Lillemor Berntson; Martin Rypdal; Ellen Nordal
Journal:  Arthritis Res Ther       Date:  2019-12-05       Impact factor: 5.156

6.  Laryngeal manifestations of rheumatoid arthritis.

Authors:  A L Hamdan; D Sarieddine
Journal:  Autoimmune Dis       Date:  2013-06-25

7.  Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study.

Authors:  Gerd Horneff; Ruben Burgos-Vargas; Tamas Constantin; Ivan Foeldvari; Jelena Vojinovic; Vyacheslav G Chasnyk; Joke Dehoorne; Violeta Panaviene; Gordana Susic; Valda Stanevica; Katarzyna Kobusinska; Zbigniew Zuber; Richard Mouy; Ingrida Rumba-Rozenfelde; Luciana Breda; Pavla Dolezalova; Chantal Job-Deslandre; Nico Wulffraat; Daniel Alvarez; Chuanbo Zang; Joseph Wajdula; Deborah Woodworth; Bonnie Vlahos; Alberto Martini; Nicolino Ruperto
Journal:  Ann Rheum Dis       Date:  2013-05-21       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.